Maximilian Schell, Felix Leonard Nägele, Götz Thomalla
{"title":"[抗凝血药治疗颅内出血-循序渐进]。","authors":"Maximilian Schell, Felix Leonard Nägele, Götz Thomalla","doi":"10.1055/a-2116-4526","DOIUrl":null,"url":null,"abstract":"<p><p>Intravenous thrombolysis for acute ischemic stroke is an indispensable tool and current standard of care in neurology. However, until recently direct therapeutic options for intracranial hemorrhage under existing anticoagulation were not available. With the introduction of two new medications - Idarucizumab and Andexanet alfa - neurologists take a more targeted approach in treating these patients.</p>","PeriodicalId":11370,"journal":{"name":"Deutsche Medizinische Wochenschrift","volume":"148 19","pages":"1252-1258"},"PeriodicalIF":0.6000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Antagonizing anticoagulants in intracranial hemorrhage - step by step].\",\"authors\":\"Maximilian Schell, Felix Leonard Nägele, Götz Thomalla\",\"doi\":\"10.1055/a-2116-4526\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Intravenous thrombolysis for acute ischemic stroke is an indispensable tool and current standard of care in neurology. However, until recently direct therapeutic options for intracranial hemorrhage under existing anticoagulation were not available. With the introduction of two new medications - Idarucizumab and Andexanet alfa - neurologists take a more targeted approach in treating these patients.</p>\",\"PeriodicalId\":11370,\"journal\":{\"name\":\"Deutsche Medizinische Wochenschrift\",\"volume\":\"148 19\",\"pages\":\"1252-1258\"},\"PeriodicalIF\":0.6000,\"publicationDate\":\"2023-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Deutsche Medizinische Wochenschrift\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1055/a-2116-4526\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/9/15 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Deutsche Medizinische Wochenschrift","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1055/a-2116-4526","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
[Antagonizing anticoagulants in intracranial hemorrhage - step by step].
Intravenous thrombolysis for acute ischemic stroke is an indispensable tool and current standard of care in neurology. However, until recently direct therapeutic options for intracranial hemorrhage under existing anticoagulation were not available. With the introduction of two new medications - Idarucizumab and Andexanet alfa - neurologists take a more targeted approach in treating these patients.
期刊介绍：
Ein Schwerpunktthema - verschiedene Perspektiven
Mit vielen praktischen Tipps und konkreten Handlungsanweisungen.
Kurz und prägnant: Aktuell informiert
Interessante Nachrichten für Sie zusammengefasst und von Experten kommentiert.
Fundiertes Fachwissen - für Einsteiger und Profis
Ein bunter Mix aus Übersichten, Fallbeispielen, Kasuistiken und Schritt-für-Schritt-Anleitungen.
Blick über den Tellerrand
Erweitern Sie Ihren Fokus über das reine Fachwissen hinaus mit "Medizin im Kontext".
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
